Global Mycoplasma Diagnostics Market Growth (Status and Outlook) 2024-2030

March 2024 | 105 pages | ID: G0BCB68F69BAEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Mycoplasma Diagnostics market size was valued at US$ 714 million in 2023. With growing demand in downstream market, the Mycoplasma Diagnostics is forecast to a readjusted size of US$ 1017.3 million by 2030 with a CAGR of 5.2% during review period.

The research report highlights the growth potential of the global Mycoplasma Diagnostics market. Mycoplasma Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Mycoplasma Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Mycoplasma Diagnostics market.

Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.

Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.

Key Features:

The report on Mycoplasma Diagnostics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Mycoplasma Diagnostics market. It may include historical data, market segmentation by Type (e.g., Kits & Reagents, Instruments), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Mycoplasma Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Mycoplasma Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Mycoplasma Diagnostics industry. This include advancements in Mycoplasma Diagnostics technology, Mycoplasma Diagnostics new entrants, Mycoplasma Diagnostics new investment, and other innovations that are shaping the future of Mycoplasma Diagnostics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Mycoplasma Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Mycoplasma Diagnostics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Mycoplasma Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Mycoplasma Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Mycoplasma Diagnostics market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Mycoplasma Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Mycoplasma Diagnostics market.

Market Segmentation:

Mycoplasma Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Kits & Reagents
  • Instruments
  • Software & Services
Segmentation by application
  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Agilent Technologies
  • Thermo Fisher Scientific
  • PromoCell
  • Charles River Laboratories International
  • Merck KGaA
  • Lonza Group
  • Takara Bio (Takara Holding Company.)
  • Savyon Diagnostics
  • Tecan Trading (Tecan Group)
  • Sartorius Stedim BioOutsource
  • American Type Culture Collection (ATCC)
  • F Hoffmann-La Roche
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mycoplasma Diagnostics Market Size 2019-2030
  2.1.2 Mycoplasma Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Mycoplasma Diagnostics Segment by Type
  2.2.1 Kits & Reagents
  2.2.2 Instruments
  2.2.3 Software & Services
2.3 Mycoplasma Diagnostics Market Size by Type
  2.3.1 Mycoplasma Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Mycoplasma Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Mycoplasma Diagnostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Diagnostic Laboratories
  2.4.3 Clinics
  2.4.4 Others
2.5 Mycoplasma Diagnostics Market Size by Application
  2.5.1 Mycoplasma Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Mycoplasma Diagnostics Market Size Market Share by Application (2019-2024)

3 MYCOPLASMA DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Mycoplasma Diagnostics Market Size Market Share by Players
  3.1.1 Global Mycoplasma Diagnostics Revenue by Players (2019-2024)
  3.1.2 Global Mycoplasma Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Mycoplasma Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MYCOPLASMA DIAGNOSTICS BY REGIONS

4.1 Mycoplasma Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Mycoplasma Diagnostics Market Size Growth (2019-2024)
4.3 APAC Mycoplasma Diagnostics Market Size Growth (2019-2024)
4.4 Europe Mycoplasma Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Mycoplasma Diagnostics Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Mycoplasma Diagnostics Market Size by Country (2019-2024)
5.2 Americas Mycoplasma Diagnostics Market Size by Type (2019-2024)
5.3 Americas Mycoplasma Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mycoplasma Diagnostics Market Size by Region (2019-2024)
6.2 APAC Mycoplasma Diagnostics Market Size by Type (2019-2024)
6.3 APAC Mycoplasma Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Mycoplasma Diagnostics by Country (2019-2024)
7.2 Europe Mycoplasma Diagnostics Market Size by Type (2019-2024)
7.3 Europe Mycoplasma Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mycoplasma Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Mycoplasma Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Mycoplasma Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MYCOPLASMA DIAGNOSTICS MARKET FORECAST

10.1 Global Mycoplasma Diagnostics Forecast by Regions (2025-2030)
  10.1.1 Global Mycoplasma Diagnostics Forecast by Regions (2025-2030)
  10.1.2 Americas Mycoplasma Diagnostics Forecast
  10.1.3 APAC Mycoplasma Diagnostics Forecast
  10.1.4 Europe Mycoplasma Diagnostics Forecast
  10.1.5 Middle East & Africa Mycoplasma Diagnostics Forecast
10.2 Americas Mycoplasma Diagnostics Forecast by Country (2025-2030)
  10.2.1 United States Mycoplasma Diagnostics Market Forecast
  10.2.2 Canada Mycoplasma Diagnostics Market Forecast
  10.2.3 Mexico Mycoplasma Diagnostics Market Forecast
  10.2.4 Brazil Mycoplasma Diagnostics Market Forecast
10.3 APAC Mycoplasma Diagnostics Forecast by Region (2025-2030)
  10.3.1 China Mycoplasma Diagnostics Market Forecast
  10.3.2 Japan Mycoplasma Diagnostics Market Forecast
  10.3.3 Korea Mycoplasma Diagnostics Market Forecast
  10.3.4 Southeast Asia Mycoplasma Diagnostics Market Forecast
  10.3.5 India Mycoplasma Diagnostics Market Forecast
  10.3.6 Australia Mycoplasma Diagnostics Market Forecast
10.4 Europe Mycoplasma Diagnostics Forecast by Country (2025-2030)
  10.4.1 Germany Mycoplasma Diagnostics Market Forecast
  10.4.2 France Mycoplasma Diagnostics Market Forecast
  10.4.3 UK Mycoplasma Diagnostics Market Forecast
  10.4.4 Italy Mycoplasma Diagnostics Market Forecast
  10.4.5 Russia Mycoplasma Diagnostics Market Forecast
10.5 Middle East & Africa Mycoplasma Diagnostics Forecast by Region (2025-2030)
  10.5.1 Egypt Mycoplasma Diagnostics Market Forecast
  10.5.2 South Africa Mycoplasma Diagnostics Market Forecast
  10.5.3 Israel Mycoplasma Diagnostics Market Forecast
  10.5.4 Turkey Mycoplasma Diagnostics Market Forecast
  10.5.5 GCC Countries Mycoplasma Diagnostics Market Forecast
10.6 Global Mycoplasma Diagnostics Forecast by Type (2025-2030)
10.7 Global Mycoplasma Diagnostics Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Agilent Technologies
  11.1.1 Agilent Technologies Company Information
  11.1.2 Agilent Technologies Mycoplasma Diagnostics Product Offered
  11.1.3 Agilent Technologies Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Agilent Technologies Main Business Overview
  11.1.5 Agilent Technologies Latest Developments
11.2 Thermo Fisher Scientific
  11.2.1 Thermo Fisher Scientific Company Information
  11.2.2 Thermo Fisher Scientific Mycoplasma Diagnostics Product Offered
  11.2.3 Thermo Fisher Scientific Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Thermo Fisher Scientific Main Business Overview
  11.2.5 Thermo Fisher Scientific Latest Developments
11.3 PromoCell
  11.3.1 PromoCell Company Information
  11.3.2 PromoCell Mycoplasma Diagnostics Product Offered
  11.3.3 PromoCell Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 PromoCell Main Business Overview
  11.3.5 PromoCell Latest Developments
11.4 Charles River Laboratories International
  11.4.1 Charles River Laboratories International Company Information
  11.4.2 Charles River Laboratories International Mycoplasma Diagnostics Product Offered
  11.4.3 Charles River Laboratories International Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Charles River Laboratories International Main Business Overview
  11.4.5 Charles River Laboratories International Latest Developments
11.5 Merck KGaA
  11.5.1 Merck KGaA Company Information
  11.5.2 Merck KGaA Mycoplasma Diagnostics Product Offered
  11.5.3 Merck KGaA Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Merck KGaA Main Business Overview
  11.5.5 Merck KGaA Latest Developments
11.6 Lonza Group
  11.6.1 Lonza Group Company Information
  11.6.2 Lonza Group Mycoplasma Diagnostics Product Offered
  11.6.3 Lonza Group Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Lonza Group Main Business Overview
  11.6.5 Lonza Group Latest Developments
11.7 Takara Bio (Takara Holding Company.)
  11.7.1 Takara Bio (Takara Holding Company.) Company Information
  11.7.2 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Product Offered
  11.7.3 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Takara Bio (Takara Holding Company.) Main Business Overview
  11.7.5 Takara Bio (Takara Holding Company.) Latest Developments
11.8 Savyon Diagnostics
  11.8.1 Savyon Diagnostics Company Information
  11.8.2 Savyon Diagnostics Mycoplasma Diagnostics Product Offered
  11.8.3 Savyon Diagnostics Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Savyon Diagnostics Main Business Overview
  11.8.5 Savyon Diagnostics Latest Developments
11.9 Tecan Trading (Tecan Group)
  11.9.1 Tecan Trading (Tecan Group) Company Information
  11.9.2 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Product Offered
  11.9.3 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Tecan Trading (Tecan Group) Main Business Overview
  11.9.5 Tecan Trading (Tecan Group) Latest Developments
11.10 Sartorius Stedim BioOutsource
  11.10.1 Sartorius Stedim BioOutsource Company Information
  11.10.2 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Product Offered
  11.10.3 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Sartorius Stedim BioOutsource Main Business Overview
  11.10.5 Sartorius Stedim BioOutsource Latest Developments
11.11 American Type Culture Collection (ATCC)
  11.11.1 American Type Culture Collection (ATCC) Company Information
  11.11.2 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Product Offered
  11.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 American Type Culture Collection (ATCC) Main Business Overview
  11.11.5 American Type Culture Collection (ATCC) Latest Developments
11.12 F Hoffmann-La Roche
  11.12.1 F Hoffmann-La Roche Company Information
  11.12.2 F Hoffmann-La Roche Mycoplasma Diagnostics Product Offered
  11.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 F Hoffmann-La Roche Main Business Overview
  11.12.5 F Hoffmann-La Roche Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Mycoplasma Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Kits & Reagents
Table 3. Major Players of Instruments
Table 4. Major Players of Software & Services
Table 5. Mycoplasma Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Mycoplasma Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Mycoplasma Diagnostics Market Size Market Share by Type (2019-2024)
Table 8. Mycoplasma Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Mycoplasma Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Mycoplasma Diagnostics Market Size Market Share by Application (2019-2024)
Table 11. Global Mycoplasma Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Mycoplasma Diagnostics Revenue Market Share by Player (2019-2024)
Table 13. Mycoplasma Diagnostics Key Players Head office and Products Offered
Table 14. Mycoplasma Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Mycoplasma Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Mycoplasma Diagnostics Market Size Market Share by Regions (2019-2024)
Table 19. Global Mycoplasma Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Mycoplasma Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Mycoplasma Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Mycoplasma Diagnostics Market Size Market Share by Country (2019-2024)
Table 23. Americas Mycoplasma Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Mycoplasma Diagnostics Market Size Market Share by Type (2019-2024)
Table 25. Americas Mycoplasma Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Mycoplasma Diagnostics Market Size Market Share by Application (2019-2024)
Table 27. APAC Mycoplasma Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Mycoplasma Diagnostics Market Size Market Share by Region (2019-2024)
Table 29. APAC Mycoplasma Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Mycoplasma Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. APAC Mycoplasma Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Mycoplasma Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. Europe Mycoplasma Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Mycoplasma Diagnostics Market Size Market Share by Country (2019-2024)
Table 35. Europe Mycoplasma Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Mycoplasma Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. Europe Mycoplasma Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Mycoplasma Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Mycoplasma Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Mycoplasma Diagnostics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Mycoplasma Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Mycoplasma Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Mycoplasma Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Mycoplasma Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Mycoplasma Diagnostics
Table 46. Key Market Challenges & Risks of Mycoplasma Diagnostics
Table 47. Key Industry Trends of Mycoplasma Diagnostics
Table 48. Global Mycoplasma Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Mycoplasma Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Mycoplasma Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Mycoplasma Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Agilent Technologies Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 53. Agilent Technologies Mycoplasma Diagnostics Product Offered
Table 54. Agilent Technologies Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Agilent Technologies Main Business
Table 56. Agilent Technologies Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Mycoplasma Diagnostics Product Offered
Table 59. Thermo Fisher Scientific Main Business
Table 60. Thermo Fisher Scientific Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. PromoCell Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 63. PromoCell Mycoplasma Diagnostics Product Offered
Table 64. PromoCell Main Business
Table 65. PromoCell Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. PromoCell Latest Developments
Table 67. Charles River Laboratories International Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 68. Charles River Laboratories International Mycoplasma Diagnostics Product Offered
Table 69. Charles River Laboratories International Main Business
Table 70. Charles River Laboratories International Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Charles River Laboratories International Latest Developments
Table 72. Merck KGaA Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 73. Merck KGaA Mycoplasma Diagnostics Product Offered
Table 74. Merck KGaA Main Business
Table 75. Merck KGaA Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Merck KGaA Latest Developments
Table 77. Lonza Group Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 78. Lonza Group Mycoplasma Diagnostics Product Offered
Table 79. Lonza Group Main Business
Table 80. Lonza Group Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Lonza Group Latest Developments
Table 82. Takara Bio (Takara Holding Company.) Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 83. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Product Offered
Table 84. Takara Bio (Takara Holding Company.) Main Business
Table 85. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Takara Bio (Takara Holding Company.) Latest Developments
Table 87. Savyon Diagnostics Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 88. Savyon Diagnostics Mycoplasma Diagnostics Product Offered
Table 89. Savyon Diagnostics Main Business
Table 90. Savyon Diagnostics Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Savyon Diagnostics Latest Developments
Table 92. Tecan Trading (Tecan Group) Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 93. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Product Offered
Table 94. Tecan Trading (Tecan Group) Main Business
Table 95. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Tecan Trading (Tecan Group) Latest Developments
Table 97. Sartorius Stedim BioOutsource Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 98. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Product Offered
Table 99. Sartorius Stedim BioOutsource Main Business
Table 100. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Sartorius Stedim BioOutsource Latest Developments
Table 102. American Type Culture Collection (ATCC) Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 103. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Product Offered
Table 104. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. American Type Culture Collection (ATCC) Main Business
Table 106. American Type Culture Collection (ATCC) Latest Developments
Table 107. F Hoffmann-La Roche Details, Company Type, Mycoplasma Diagnostics Area Served and Its Competitors
Table 108. F Hoffmann-La Roche Mycoplasma Diagnostics Product Offered
Table 109. F Hoffmann-La Roche Main Business
Table 110. F Hoffmann-La Roche Mycoplasma Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. F Hoffmann-La Roche Latest Developments

LIST OF FIGURES

Figure 1. Mycoplasma Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mycoplasma Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Mycoplasma Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Mycoplasma Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Mycoplasma Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Mycoplasma Diagnostics Market Size Market Share by Type in 2023
Figure 10. Mycoplasma Diagnostics in Hospitals
Figure 11. Global Mycoplasma Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Mycoplasma Diagnostics in Diagnostic Laboratories
Figure 13. Global Mycoplasma Diagnostics Market: Diagnostic Laboratories (2019-2024) & ($ Millions)
Figure 14. Mycoplasma Diagnostics in Clinics
Figure 15. Global Mycoplasma Diagnostics Market: Clinics (2019-2024) & ($ Millions)
Figure 16. Mycoplasma Diagnostics in Others
Figure 17. Global Mycoplasma Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Mycoplasma Diagnostics Market Size Market Share by Application in 2023
Figure 19. Global Mycoplasma Diagnostics Revenue Market Share by Player in 2023
Figure 20. Global Mycoplasma Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Mycoplasma Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. APAC Mycoplasma Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Europe Mycoplasma Diagnostics Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Mycoplasma Diagnostics Market Size 2019-2024 ($ Millions)
Figure 25. Americas Mycoplasma Diagnostics Value Market Share by Country in 2023
Figure 26. United States Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Mycoplasma Diagnostics Market Size Market Share by Region in 2023
Figure 31. APAC Mycoplasma Diagnostics Market Size Market Share by Type in 2023
Figure 32. APAC Mycoplasma Diagnostics Market Size Market Share by Application in 2023
Figure 33. China Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Mycoplasma Diagnostics Market Size Market Share by Country in 2023
Figure 40. Europe Mycoplasma Diagnostics Market Size Market Share by Type (2019-2024)
Figure 41. Europe Mycoplasma Diagnostics Market Size Market Share by Application (2019-2024)
Figure 42. Germany Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Mycoplasma Diagnostics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Mycoplasma Diagnostics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Mycoplasma Diagnostics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Mycoplasma Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. APAC Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. Europe Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. United States Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Canada Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. China Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Japan Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Korea Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. India Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Australia Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Germany Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. France Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. UK Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Italy Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Russia Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Spain Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Israel Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Mycoplasma Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. Global Mycoplasma Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Mycoplasma Diagnostics Market Size Market Share Forecast by Application (2025-2030)


More Publications